Março 2015
Artigo do mês

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease.
Vande Casteele, Khanna, Levesque, Stitt, Zou GY, Singh, Lockton, Hauenstein, Ohrmund, Greenberg, Rutgeerts, Gils, Sandborn, Vermeire, Feagan.

Nota: Caso deseje o artigo, contacte-nos.

Educational Workshop

Inscrições até 28 março


Formulário inscrição

Programa


Projectos de Investigação Científica para 2015

PhDI - Padrões de hipermetilação na displasia no contexto de Doença Inflamatória Intestinal
Protocolo e CRF no site do GEDII

BIOAZA - Impact of AZAthioprine in inducing and maintaining clinical, BIOmarkers and endoscopic remission among patients with steroid-dependent Crohn’s Disease: a 2-year longitudinal analysis from the GEDII Registry

MICRA - An epidemiological study to determine the prevalence of Microscopic Colitis and describe its clinical and histological features among patients with symptoms of chRonic watery diarrhea submitted to colonoscopy Attending to the Portuguese gastroenterology setting

DIRECT - Study to investigate the correlation of fecal calprotectin with serum Drug levels and development of antI-dRug antibodiEs among adult patients with inflammatory bowel disease reCeiving anti-TNF-alfa treatment

SYMREGISTER - A study in the real-world practice to evaluate the impact of biosimilar infliximab (Inflectra) in clinical outcomes in patients with inflammatory bowel diseases: a 2-year longitudinal analysis from the GEDII Registry

ICARE - Ibd CAncer and seRious infections in Europe
 
Agenda
01 de março de 2023
21st ECCO Intensive Course for Trainees in IBD
De 19 de abril a 21 de abril de 2023
Reunião Anual GEDII
De 25 de maio a 28 de maio de 2023
5 Nations Meeting in IBD
©2022 GEDII - Grupo de Estudos da Doença Inflamatória Intestinal | Todos os direitos reservados | Links úteis | Termos e condiçoes
Desenvolvido por DogmaSis